Capital Research Global Investors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
Other funds holding CBPO
HA
YCMGA
MCP
Capital Research Global Investors's CBPO Position: Q4 2019 in Review
Capital Research Global Investors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2019, closing a stake of 4,199,958 shares — an estimated $481M sold.
Capital Research Global Investors first reported a position in CBPO in Q4 2015 and held it in 16 quarters. The position peaked at $481M in Q3 2019. 87 funds tracked by Wall St. Rank hold CBPO as of Q4 2019.
- Capital Research Global Investors reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2019 after selling out during the quarter.
- Capital Research Global Investors sold 4,199,958 China Biologic Products Holdings, Inc. shares in Q4 2019, an estimated $481M.
- Capital Research Global Investors first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 16 quarters.
- Capital Research Global Investors's China Biologic Products Holdings, Inc. position peaked at $481M in Q3 2019.
- 87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2019.
Based on Capital Research Global Investors's 13F filing for Q4 2019, filed 18 Feb 2020.